ОСОБЕННОСТИ ИММУНОПАТОГЕНЕЗА И ХРОНИЗАЦИИ МИОКАРДИТА КАК ФУНДАМЕНТ ДЛЯ РАЗРАБОТКИ КЛИНИЧЕСКОГО ПРОТОКОЛА ИММУНОГЕНОДИАГНОСТИКИ И ИММУНОГЕНОМОНИТОРИНГА

1. Антонов В.П., Цинзерлинг В.А. Современное состояние проблемы хронических и медленных нейроинфекций // Архив патологии, 2001, 63(1), 47-51.

2. Борисов И. А. Пиелонефрит. Нефрология, 2000, 383 – 399

3. Палеев Ф.Н., Палеев Н.Р., Котова А.А. и др. Аутоиммунный миокардит: современные аспекты иммунопатогенеза // Вестн. РАМН. – 2002. – № 10. – С.52-56.

4. Ройтберг Г.Е., Струтынский. А.В.”Внутренние болезни. Сердечно-сосудистая система”. М.: Издательство БИНОМ, 2003. – 856 с.

5. Сепиашвили Р.И., Балмасова И.П.. Физиология естественных киллеров. М. Медицина Здоровье, 2005.

6. Синюхин В. Н., Ковальчук Л. В., Ходырева Л. А. и др. Иммунологические аспекты острого пиелонефрита//Урология, 2002,1, 7-11.

7. Сучков С.В., Шогенов З.С., Хитров А.Н. и др. Постинфекционный аутоиммунный синдром: особенности патогенеза и современные протоколы клинической иммуногено-диагностики// Терапевтический архив 2007, 79(4), 71-76.

8. Carballido J.A., Alvarez-Mon M., Olivier C. Inflammatory pathology in urology. Standardization //Actas Urol Esp, 2003, 27(3), 173-179.

9. Afanasyeva M., Wang Y., Kaya Z. et. al. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype // Am. J. Path. – 2001. – V. 159, No. 1. – P. 193-203.

10. Andres O., Obojes K., Kim K.S. et al. CD46- and CD150- independent endothelial cell infection with wild-type measles viruses//J Gen Virol, 2003, 84(Pt 5), 1189-1197.

11. Bach J.F. Infections and autoimmunity//Rev. Med. Interne, 2005,1, 32-34.

12. Bauer J., Rauschka H., Lassmann H. Inflammation in the nervous system: the human perspective // Glia, 2001, 36(2), 235-243.

13. Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? // Nat. Immunol., 2001, 2(9), 797-801.

14. Capdevila Cogul E., Martin Ibanez I., et al. First urinary tract infection in healthy infants: epidemiology, diagnosis and treatment // An Esp Pediatr., 2001, 55(4), 310-314.

15. Carballido J.A., Alvarez-Mon M., Olivier C. Inflammatory pathology in urology Standardization // Actas Urol Esp, 2003, 27(3), 173-179.

16. Cheung M.C. et al. A cryptic cause of cryptococcal meningitis, 2003, 168(4).

17. Chijioke A. Current concepts on pathogenesis of renal tuberculosis// West Afr J Med., 2001, 20(2), 107-110.

18. Eriksson U., Kurrer M.O. et. al. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma // J. Immunol. – 2001. – V.167, No.9. – P. 5464-5469

19. Fairweather D, Kaya Z, Shellam GR et al. From infection to autoimmunity // J Autoimmun 2001 May;16(3):175-86

20. Figdor C.G. Molecular characterization of dendritic cells operating at the interface of innate or acquired immunity //Pathol Biol (Paris), 2003, 51(2), 61-63.

21. Fremeaux-Bacchi V., Dragon-Durey M.A., Blouin J. et al. Investigation of the complement system in clinical practice // Ann Med Interne (Paris), 2003, 154 (8), 529-540.

22. Fujinami R.S., von Herrath M.G., Christen U. et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease // Clin. Microbiol. Rev., 2006, 19(1), 80-94.

23. Furukawa Y., Kobuke K., Matsumori A. Role of cytokines in autoimmune myocarditis and cardiomyopathy // Autoimmunity. – 2001. V. 34, No.3. – P. 165-168.

24. Fuse K., Kodama M., Hanawa H.et al. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis // Clin. Exp. Immunol. – 2001. – V. 124, No.3. – P. 346-352.

25. Grabie N, Delfs MW, Westrich JR et al. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis // J Clin Invest. 2003 Mar;111(5):671-80

26. Huber S. T cells in coxsackievirus-induced myocarditis // Viral Immunol. 2004;17(2):152-64.

27. Khitrov A.N., Shogenov Z.S., Tretyak E.B. et al. Postinfectious immunodeficiency and autoimmunity: pathogenic and clinical values and implications // Expert Review of Clinical Immunology, 2007, 3(3), 323-331.

28. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis // Lancet Infect Dis, 2002, 2(12), 721-736.

29. Kurrer M.O., Kopf M., Penninger J.M. et al. Cytokines that regulate autoimmune myocarditis // Swiss.med.Wkly. – 2002. – V. 132. – P. 408-413.

30. Laestadius A., Soderblom T., Aperia A. et al. Developmental aspects of Escherichia coli-induced innate responses in rat renal epithelial cells // Pediatr Res, 2003, 54(4), 536-541.

31. Manges A.R., Dietrich P.S., Riley L.W. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis // Clin Infect Dis., 2004,1, 38(3), 329-334.

32. McGreal E.P., Miller J.L., Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors // Current Opinion in Immunol., 2005,17(1), 18 – 24.

33. Molina V., Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity // Autoimmunity. – 2005. – Vol. 38. – No. 3. – P. 235-245.

34. Nathanson S., Deschenes G. Urinary antimicrobial prophylaxis// Arch Pediatr, 2002, 9(5), 511-518.

35. Roos A., Bouwman L.N., Munoz J. et al. Functional characterization of the lectin pathway of complement in human serum // Mol Immunol. 2003, 39(11), 655-668.

36. Schaller B. Craniocerebral trauma-new pathophysiological and therapeutic viewpoints // Swiss Surg, 2002, 8(4), 145-158.

37. Shoenfeld Y., Rose N.R. Infection and autoimmunity. – Elsevier B.V., 2004, 14, 32-37.

38. Soulas P., Woods A., Jaulhac B. et al. Autoantigen. innate immunity and T cells cooperate to break B cell tolerance during bacterial infection // J. Clin. Invest. – 2005. – Vol. 115. – No. 8. – P. 2257-2267.

39. Tamura H., Ogata K., Dong H. et al. Immunology of B7-H1 and its roles in human diseases// Int J Hemotol. 2003, 78(4), 321-328.

40. Vila J., Simon K., Ruiz J. et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? // J Infect Dis, 2002, 1, 186(7), 1039-1042.